CN113272317A - 正交蛋白异二聚体 - Google Patents

正交蛋白异二聚体 Download PDF

Info

Publication number
CN113272317A
CN113272317A CN201980073145.5A CN201980073145A CN113272317A CN 113272317 A CN113272317 A CN 113272317A CN 201980073145 A CN201980073145 A CN 201980073145A CN 113272317 A CN113272317 A CN 113272317A
Authority
CN
China
Prior art keywords
polypeptide
target
domain
amino acid
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980073145.5A
Other languages
English (en)
Chinese (zh)
Inventor
陈子博
S·博伊肯
S·贝梅奥
R·A·兰根
D·贝克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WASHINGTON, University of
Original Assignee
WASHINGTON, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WASHINGTON, University of filed Critical WASHINGTON, University of
Publication of CN113272317A publication Critical patent/CN113272317A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/002—Biomolecular computers, i.e. using biomolecules, proteins, cells
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • H—ELECTRICITY
    • H03—ELECTRONIC CIRCUITRY
    • H03K—PULSE TECHNIQUE
    • H03K19/00—Logic circuits, i.e. having at least two inputs acting on one output; Inverting circuits
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/10—Boolean models
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/30—Dynamic-time models
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/914—Protein engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Theoretical Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Mathematical Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Computing Systems (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Artificial Intelligence (AREA)
CN201980073145.5A 2018-11-02 2019-11-04 正交蛋白异二聚体 Pending CN113272317A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862755264P 2018-11-02 2018-11-02
US62/755,264 2018-11-02
US201962904800P 2019-09-24 2019-09-24
US62/904,800 2019-09-24
PCT/US2019/059654 WO2020093043A1 (en) 2018-11-02 2019-11-04 Orthogonal protein heterodimers

Publications (1)

Publication Number Publication Date
CN113272317A true CN113272317A (zh) 2021-08-17

Family

ID=68655751

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980073145.5A Pending CN113272317A (zh) 2018-11-02 2019-11-04 正交蛋白异二聚体

Country Status (8)

Country Link
US (4) US11820800B2 (cg-RX-API-DMAC7.html)
EP (1) EP3873919A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022505866A (cg-RX-API-DMAC7.html)
KR (1) KR20210087959A (cg-RX-API-DMAC7.html)
CN (1) CN113272317A (cg-RX-API-DMAC7.html)
AU (1) AU2019371462A1 (cg-RX-API-DMAC7.html)
CA (1) CA3117841A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020093043A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210087959A (ko) * 2018-11-02 2021-07-13 유니버시티 오브 워싱톤 직교 단백질 이종이량체
US20230399660A1 (en) * 2020-10-23 2023-12-14 Altius Institute For Biomedical Sciences Cell Permeable Proteins for Genome Engineering
WO2022169913A2 (en) * 2021-02-02 2022-08-11 Outpace Bio, Inc. Synthetic degrader system for targeted protein degradation
WO2023288190A1 (en) * 2021-07-13 2023-01-19 University Of Washington Modular reconfigurable asymmetric protein assemblies
WO2023150649A2 (en) * 2022-02-02 2023-08-10 Outpace Bio, Inc. Synthetic degrader system for targeted protein degradation
US20250136652A1 (en) * 2022-03-02 2025-05-01 The Regents Of The University Of California Fusion protein for targeting recombinant proteins for degradation
WO2024026465A1 (en) * 2022-07-29 2024-02-01 The Broad Institute, Inc. Programmable pattern recognition compositions
WO2026055533A1 (en) * 2024-09-06 2026-03-12 The Regents Of The University Of California Synthetic receptors for engineered ligands

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012988A1 (en) * 1995-10-06 1997-04-10 Pence Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
CN1306572A (zh) * 1998-05-19 2001-08-01 阿维德克斯有限公司 可溶性t细胞受体
WO2004007530A2 (en) * 2002-07-17 2004-01-22 The Center For Blood Research, Inc. Modified proteins stabilized in a desired conformation and methods for producing same
US20100305304A1 (en) * 2007-09-07 2010-12-02 Complix Nv Non-natural proteinaceous scaffold made of three non-covalently associated peptides

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1999154T3 (da) 2006-03-24 2012-12-03 Merck Patent Gmbh Fremstillede heterodimere proteindomæner
US20110224404A1 (en) 2010-03-11 2011-09-15 Florida State University Research Foundation Method for development of a peptide building block useful for de novo protein design
EP3436470A4 (en) 2016-04-01 2019-11-20 University of Washington POLYPEPTIDES FOR THE PREPARATION OF HOMOOLIGOMERS WITH MODULAR HYDROGEN BONDING NETWORKED SPECIFICITY AND THEIR DESIGN
US20180068054A1 (en) * 2016-09-06 2018-03-08 University Of Washington Hyperstable Constrained Peptides and Their Design
US10818377B2 (en) * 2016-11-16 2020-10-27 University Of Washington Computational design of self-assembling cyclic protein homo-oligomers
US20210363214A1 (en) * 2018-03-01 2021-11-25 University Of Washington Transmembrane polypeptides
CN112512544B (zh) * 2018-07-19 2025-09-09 华盛顿大学 蛋白质开关的全新设计
US20210324011A1 (en) * 2018-10-25 2021-10-21 University Of Washington Self-assembling protein homo-polymers
KR20210087959A (ko) * 2018-11-02 2021-07-13 유니버시티 오브 워싱톤 직교 단백질 이종이량체
KR20210111761A (ko) * 2018-12-04 2021-09-13 유니버시티 오브 워싱턴 단백질 기능 및 상호작용을 제어하기 위한 시약 및 방법
US12583896B2 (en) * 2019-01-07 2026-03-24 The Regents Of The University Of California Caged-degron-based molecular feedback circuits and methods of using the same
EP3908592A1 (en) * 2019-01-07 2021-11-17 University of Washington De novo design of protein switches for tunable control of protein degradation
WO2020214549A1 (en) * 2019-04-15 2020-10-22 University Of Washington Self-assembling 2d arrays with de novo protein building blocks
US20220144895A1 (en) * 2019-04-18 2022-05-12 University Of Washington De novo design of tunable ph-driven conformational switches
WO2020257225A1 (en) * 2019-06-17 2020-12-24 University Of Washington De novo design of phosphorylation inducible protein switches (phospho-switches)
WO2021158849A1 (en) * 2020-02-07 2021-08-12 University Of Washington Multipartite and circularly permuted beta-barrel polypeptides and methods for their use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012988A1 (en) * 1995-10-06 1997-04-10 Pence Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
CN1306572A (zh) * 1998-05-19 2001-08-01 阿维德克斯有限公司 可溶性t细胞受体
WO2004007530A2 (en) * 2002-07-17 2004-01-22 The Center For Blood Research, Inc. Modified proteins stabilized in a desired conformation and methods for producing same
US20100305304A1 (en) * 2007-09-07 2010-12-02 Complix Nv Non-natural proteinaceous scaffold made of three non-covalently associated peptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
E K O\'SHEA等: "Peptide \'Velcro\': design of a heterodimeric coiled coil", CURRENT BIOLOGY, vol. 3, no. 10, pages 658 - 667 *

Also Published As

Publication number Publication date
US20220017579A1 (en) 2022-01-20
AU2019371462A1 (en) 2021-05-20
JP2024149492A (ja) 2024-10-18
WO2020093043A1 (en) 2020-05-07
JP2022505866A (ja) 2022-01-14
US20220098250A1 (en) 2022-03-31
EP3873919A1 (en) 2021-09-08
US20210355175A1 (en) 2021-11-18
CA3117841A1 (en) 2020-05-07
KR20210087959A (ko) 2021-07-13
US11820800B2 (en) 2023-11-21
US20240101615A1 (en) 2024-03-28

Similar Documents

Publication Publication Date Title
US20240101615A1 (en) Orthogonal protein heterodimers
Zuo et al. Chimeric protein probes for C5a receptors through fusion of the anaphylatoxin C5a core region with a small-molecule antagonist
Tiede et al. Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications
Karatan et al. Molecular recognition properties of FN3 monobodies that bind the Src SH3 domain
CN112512544A (zh) 蛋白质开关的全新设计
US8481491B2 (en) Scaffold polypeptides for heterologous peptide display
CN111945231B (zh) 基于二硫键精准配对构建噬菌体展示多元环肽库的方法
Signarvic et al. De novo design of a molecular switch: phosphorylation-dependent association of designed peptides
Jagadish et al. Recombinant expression of cyclotides using split inteins
Patel et al. Selection of a high-affinity WW domain against the extracellular region of VEGF receptor isoform-2 from a combinatorial library using CIS display
Edgell et al. De novo designed protein-interaction modules for in-cell applications
Chen et al. Expression, purification, and micelle reconstitution of antimicrobial piscidin 1 and piscidin 3 for NMR studies
Pham et al. Design of functional globular β‐Sheet miniproteins
Mason et al. Role of hydrophobic and electrostatic interactions in coiled coil stability and specificity
WO1999051625A9 (en) Peptides causing formation of compact structures
Napier Models of Auxin Binding.
Leng et al. De novo designed 3-helix bundle peptides and proteins with controlled topology and stability
Lorenz et al. The filamentous phages fd and IF1 use different mechanisms to infect Escherichia coli
Meyer et al. Insights into molecular interactions between the juxtamembrane and kinase subdomains of the Arabidopsis Crinkly-4 receptor-like kinase
US20240368233A1 (en) Modular reconfigurable asymmetric protein assemblies
Deng et al. A heterospecific leucine zipper tetramer
Petters et al. Design, expression and characterization of a highly stable tetratricopeptide-based protein scaffold for phage display application
Nikolaev et al. Rethinking Leucine Zipper–a ubiquitous signal transduction motif
Tököli Design Strategies for Protein-Protein Interaction Inhibitors Using Non-Natural Amino Acids
Xu Interrogation of Intermolecular Interactions in Liquid–Liquid Phase Separation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210817